脂质介质网络作为眼表治疗和生物标志物的潜力。
The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.
机构信息
School of Optometry, University of California Berkeley, Berkeley, CA, 94720, USA; Vision Science Program, University of California Berkeley, Berkeley, CA, 94720, USA.
Department of Medicine and Anesthesia, University of California, San Francisco, CA, USA; Cardiovascular Research Institute, University of California, San Francisco, CA, USA.
出版信息
Ocul Surf. 2021 Jan;19:104-114. doi: 10.1016/j.jtos.2020.04.008. Epub 2020 Apr 29.
Abstract
In the last twenty years an impressive body of evidence in diverse inflammatory animal disease models and human tissues, has established polyunsaturated fatty acids (PUFA) derived specialized-pro-resolving mediators (SPM), as essential mediators for controlling acute inflammation, immune responses, wound healing and for resolving acute inflammation in many non-ocular tissues. SPM pathways and receptors are highly expressed in the ocular surface where they regulate wound healing, nerve regeneration, innate immunity and sex-specific regulation of auto-immune responses. Recent evidence indicates that in the eye these resident SPM networks are important for maintaining ocular surface health and immune homeostasis. Here, we will review and discuss evidence for SPMs and other PUFA-derived mediators as important endogenous regulators, biomarkers for ocular surface health and disease and their therapeutic potential.
摘要
在过去的二十年中，在各种炎症性动物疾病模型和人体组织中，令人印象深刻的证据表明，多不饱和脂肪酸（PUFA）衍生的特异性促解决介质（SPM）是控制急性炎症、免疫反应、伤口愈合和解决许多非眼部组织急性炎症的必需介质。SPM 途径和受体在眼部表面高度表达，在眼部表面调节伤口愈合、神经再生、先天免疫和自身免疫反应的性别特异性调节。最近的证据表明，在眼睛中，这些常驻 SPM 网络对于维持眼部表面健康和免疫稳态非常重要。在这里，我们将回顾和讨论 SPM 以及其他 PUFA 衍生介质作为重要的内源性调节剂、眼部表面健康和疾病的生物标志物及其治疗潜力的证据。
相似文献
1
The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.脂质介质网络作为眼表治疗和生物标志物的潜力。
Ocul Surf. 2021 Jan;19:104-114. doi: 10.1016/j.jtos.2020.04.008. Epub 2020 Apr 29.
2
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.E 系列消退素代谢组、专门的促消退介质（SPM）的生物合成及其立体化学在炎症消退中的关键作用：为长期新冠、人体临床试验和靶向精准营养制备 SPM。
Semin Immunol. 2022 Jan;59:101597. doi: 10.1016/j.smim.2022.101597. Epub 2022 Feb 16.
3
Roles of specialized pro-resolving mediators and omega-3 polyunsaturated fatty acids in periodontal inflammation and impact on oral microbiota.特异性促消退介质和ω-3多不饱和脂肪酸在牙周炎症中的作用及其对口腔微生物群的影响。
Front Oral Health. 2023 Jul 25;4:1217088. doi: 10.3389/froh.2023.1217088. eCollection 2023.
4
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.急性炎症的消退机制：消退过程中新型促消退脂质介质
Semin Immunol. 2015 May;27(3):200-15. doi: 10.1016/j.smim.2015.03.004. Epub 2015 Apr 7.
5
Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation.低剂量促解决介质可使微生物炎症的解决反应时间重置。
Mol Med. 2024 Sep 18;30(1):153. doi: 10.1186/s10020-024-00877-w.
6
Resolution of inflammation in oral diseases.口腔疾病的炎症消退。
Pharmacol Ther. 2023 Jul;247:108453. doi: 10.1016/j.pharmthera.2023.108453. Epub 2023 May 25.
7
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction.ST 段抬高型心肌梗死患者中特异性促解决脂质介质的早期增加。
EBioMedicine. 2019 Aug;46:264-273. doi: 10.1016/j.ebiom.2019.07.024. Epub 2019 Jul 22.
8
Developments of specialized pro-resolving mediators in periodontitis.牙周炎中特异性促解决介质的研究进展。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Feb 1;39(1):94-98. doi: 10.7518/hxkq.2021.01.014.
9
Specialized pro-resolving mediators as modulators of immune responses.特异性促解决介质作为免疫反应的调节剂。
Semin Immunol. 2022 Jan;59:101605. doi: 10.1016/j.smim.2022.101605. Epub 2022 Jun 2.
10
Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders.特异性促消退介质在减轻神经退行性疾病神经炎症中的作用。
Front Aging Neurosci. 2022 Feb 17;14:780811. doi: 10.3389/fnagi.2022.780811. eCollection 2022.
引用本文的文献
1
Adult male-specific inverse association between dry eye disease and intraocular pressure: KNHANES 2010-2012.2010 - 2012年韩国国家健康与营养检查调查：干眼症与眼压之间成年男性特有的负相关关系
PLoS One. 2025 Feb 14;20(2):e0315010. doi: 10.1371/journal.pone.0315010. eCollection 2025.
2
Regulation of disease-associated microglia in the optic nerve by lipoxin B and ocular hypertension.脂氧素 B 通过对眼压的调节作用抑制视神经病变中的小胶质细胞。
Mol Neurodegener. 2024 Nov 20;19(1):86. doi: 10.1186/s13024-024-00775-z.
3
Dysregulation of neuroprotective lipoxin pathway in astrocytes in response to cytokines and ocular hypertension.细胞因子和眼内高压对星形胶质细胞中神经保护脂氧素通路的失调调控。
Acta Neuropathol Commun. 2024 Apr 12;12(1):58. doi: 10.1186/s40478-024-01767-2.
4
Regulation of Diseases-Associated Microglia in the Optic Nerve by Lipoxin B and Ocular Hypertension.脂氧素B与高眼压对视神经中疾病相关小胶质细胞的调控
bioRxiv. 2024 Oct 28:2024.03.18.585452. doi: 10.1101/2024.03.18.585452.
5
Mouse Model of Nitrogen Mustard Ocular Surface Injury Characterization and Sphingolipid Signaling.氮芥眼部表面损伤的小鼠模型表征和神经酰胺信号。
Int J Mol Sci. 2024 Jan 6;25(2):742. doi: 10.3390/ijms25020742.
6
Untargeted and temporal analysis of retinal lipidome in bacterial endophthalmitis.细菌性眼内炎视网膜脂质组的非靶向和时序分析
Prostaglandins Other Lipid Mediat. 2024 Apr;171:106806. doi: 10.1016/j.prostaglandins.2023.106806. Epub 2024 Jan 5.
7
Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome.脂氧素 A4（LXA4）可减轻碱诱导的角膜炎症和新生血管形成，并上调修复转录组。
Biomolecules. 2023 May 13;13(5):831. doi: 10.3390/biom13050831.
8
Corneal deposits and nerve alterations in Bietti Corneoretinal Crystalline Dystrophy imaged using in vivo confocal microscopy.应用活体共聚焦显微镜观察到的 Bietti 角膜-视网膜晶体营养不良的角膜沉积物和神经改变。
Graefes Arch Clin Exp Ophthalmol. 2023 Jul;261(7):1941-1949. doi: 10.1007/s00417-023-05987-5. Epub 2023 Feb 14.
9
Potential Properties of Natural Nutraceuticals and Antioxidants in Age-Related Eye Disorders.天然营养保健品和抗氧化剂在年龄相关性眼部疾病中的潜在特性
Life (Basel). 2022 Dec 27;13(1):77. doi: 10.3390/life13010077.
10
The role of sphingolipids in meibomian gland dysfunction and ocular surface inflammation.鞘脂在睑板腺功能障碍和眼表炎症中的作用。
Ocul Surf. 2022 Oct;26:100-110. doi: 10.1016/j.jtos.2022.07.006. Epub 2022 Aug 13.
本文引用的文献
1
A novel role for lipoxin A in driving a lymph node-eye axis that controls autoimmunity to the neuroretina.脂氧素 A 在驱动控制神经视网膜自身免疫的淋巴结-眼轴中的新作用。
Elife. 2020 Mar 2;9:e51102. doi: 10.7554/eLife.51102.
2
Enriched Marine Oil Supplements Increase Peripheral Blood Specialized Pro-Resolving Mediators Concentrations and Reprogram Host Immune Responses: A Randomized Double-Blind Placebo-Controlled Study.富含海洋油的补充剂增加外周血特异性促解决介质的浓度并重新编程宿主免疫反应：一项随机双盲安慰剂对照研究。
Circ Res. 2020 Jan 3;126(1):75-90. doi: 10.1161/CIRCRESAHA.119.315506. Epub 2019 Dec 12.
3
The Influence of Dietary Fatty Acids on Immune Responses.膳食脂肪酸对免疫应答的影响。
Nutrients. 2019 Dec 6;11(12):2990. doi: 10.3390/nu11122990.
4
GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections.GPR101 介导 RvD5n-3 DPA 在关节炎和感染中的促解决作用。
J Clin Invest. 2020 Jan 2;130(1):359-373. doi: 10.1172/JCI131609.
5
Lipid mediators of inflammation and Resolution in individuals with tuberculosis and tuberculosis-Diabetes.炎症和解决的脂质介质在结核和结核-糖尿病个体中。
Prostaglandins Other Lipid Mediat. 2020 Apr;147:106398. doi: 10.1016/j.prostaglandins.2019.106398. Epub 2019 Nov 11.
6
Immunoresolvent Resolvin D1 Maintains the Health of the Ocular Surface.免疫溶剂型 resolvin D1 维持眼表面健康。
Adv Exp Med Biol. 2019;1161:13-25. doi: 10.1007/978-3-030-21735-8_3.
7
Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.脑脊髓液中促解决介质谱与结核性脑膜炎成人患者的疾病严重程度和结局相关。
FASEB J. 2019 Nov;33(11):13028-13039. doi: 10.1096/fj.201901590R. Epub 2019 Oct 5.
8
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease.解析素 D1 可减轻神经炎症，预防帕金森病大鼠模型的早期病变。
Nat Commun. 2019 Sep 2;10(1):3945. doi: 10.1038/s41467-019-11928-w.
9
Immune Regulatory Mediators in Plasma from Patients With Acute Decompensation Are Associated With 3-Month Mortality.急性失代偿期患者血浆中的免疫调节介质与 3 个月死亡率相关。
Clin Gastroenterol Hepatol. 2020 May;18(5):1207-1215.e6. doi: 10.1016/j.cgh.2019.08.036. Epub 2019 Aug 22.
10
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction.ST 段抬高型心肌梗死患者中特异性促解决脂质介质的早期增加。
EBioMedicine. 2019 Aug;46:264-273. doi: 10.1016/j.ebiom.2019.07.024. Epub 2019 Jul 22.
Zotero 插件